Product Name

Voriconazole

CAS Number

137234-62-9

LGM Pharma is an API distributor. LGM Pharma can supply CGMP and/or DMF products, subject to availability and manufacturer requirements. LGM Pharma does not sell or supply APIs or finished dosage products to individual patients, doctors, pharmacies, or any pharmaceutical companies.

Questions? Call our customer API support number 1-(800)-881-8210

Product Name:
Voriconazole
CAS Number:
137234-62-9
Indication:

Invasive aspergillosis

Vfend 200mg oral tabletVoriconazole has become the new standard of care in the treatment of invasive aspergillosis, which may occur in immunocompromised patients, including allogeneic BMT, other hematologic cancers, and solid organ transplants. This is based on the results of a large, randomized study in which voriconazole proved superior to amphotericin B with 53% complete or partial response, compared with 32% for amphotericin B. Importantly, voriconazole also offered a 22% greater survival benefit over amphotericin B, with 71% of voriconazole patients still alive at week 12. Only 13% of patients who received initial therapy with voriconazole died from invasive aspergillosis, compared with 29% of patients who initially received amphotericin B. Voriconazole was also better tolerated than amphotericin B, with significantly fewer serious adverse effects and a longer duration of therapy. Note that the design of these studies has been called into question, and some still consider (liposomal) amphotericin B as the drug of choice.
IUPAC:
(R-(R*, S*))-alpha-(2, 4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1, 2, 4-triazol-1-ylmethyl)-4-pyrimidineethanol
ATC:
J02AC03
PubChem:
71616
DrugBank:
APRD00543
Formula:
C16-H14-F3-N5-O
Molecular Mass:
349.315
Synonyms:
(alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol, 4-Pyrimidineethanol, alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-, (alphaR,betaS)-, DRG-0301, UK-109,496, UNII-JFU09I87TR, VFEND, VFEND I.V., Voriconazole, Vorikonazole, VRC
SMILES:
c1(c([C@@]([C@H](c2ncncc2F)C)(Cn2cncn2)O)ccc(F)c1)F
InChi:
1S/C16H14F3N5O/c1-10(15-14(19)5-20-7-22-15)16(25,6-24-9-21-8-23-24)12-3-2-11(17)4-13(12)18/h2-5,7-10,25H,6H2,1H3/t10-,16+/m0/s1

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

LGM currently offers Monoclonal Antibodies (mAbs) for non-GMP/R&D use. Please inquire about Monoclonal Antibodies produced under GMP conditions.

Questions? Call our customer API support number 1-(800)-881-8210. 

Ask us about this product

API’s From Quality Manufacturers:

  • Streamlined API supply towards initial research stages as well as larger quantities of cGMP material for clinical trials and product commercialization
  • Premium quality GMP certified and fully accredited API manufacturing plants
  • Technical packages as well as access to filed DMF, ASMF or CEP (subject to availability)
  • Regulatory and technical assistance towards any submission type based on specific customer requirements

Find an API Product

SEARCH
Generic filters